-
Mashup Score: 0European Study Finds the Abbott Cardiomems Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations - 11 month(s) ago
May 25, 2023 — New data presented from an investigator-sponsored European trial found managing indicated1 heart failure patients with Abbott’s CardioMEMS HF System resulted in a significant1 improvement in patient-reported quality-of-life scores as early as three months after use with the remote monitoring sensor. The MONITOR-HF trial also resulted in a significant 44% reduction in heart…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
@DAICeditor @AbbottCardio #MONITOR_HF is the third randomized, controlled #trial globally to show a significant health benefit for indicated #heartfailure patients: https://t.co/Zhqp8hVBaE